20 ML Zynyz 25 MG/ML Injection
- RxCUI
- 2632991
- RxNorm name
- 20 ML Zynyz 25 MG/ML Injection
- Display name
- 20 ML Zynyz 25 MG/ML Injection
- Full name
- 20 ML Zynyz 25 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761334 | Zynyz | retifanlimab-dlwr | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 109648d0-d30a-42fc-8273-39cb1540a751 | ZYNYZ 500 MG in 20 ML Injection [PSN] · 20 ML retifanlimab-dlwr 25 MG/ML Injection [Zynyz] [SBD] · 20 ML Zynyz 25 MG/ML Injection [SY] · Zynyz 500 MG per 20 ML Injection [SY] | 4 | 16 | These highlights do not include all the information needed to use ZYNYZ safely and effectively. See full prescribing information for ZYNYZ . ZYNYZ ® ( retifanlimab-dlwr ) injection, for intravenous use Initial U.S. Approval: 2023 | 20260518 |